Biotech Stock 685% Draws Big Investment Amid FDA Filings
A biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
Assess top-performing Hyd etfs for retirees, comparing yields, risk, and track records to help you choose a fund aligned with retirement goals.
27,995 articlesA biotech stock that sprinted 685% in months drew a sizeable institutional bet as it pressed ahead with two FDA filin...
A growing share of Americans are drawn to traveling alone, even as hesitation persists. This guide breaks down the fi...
Oil hovers above $100 as the U.S. weighs a potential ground war in Iran. The move could ripple through gas prices, in...
New December 2025 data underscores a sizable gap in benefits for claiming at 62 versus waiting to 70, changing how in...
As AI hardware demand strengthens, the buy everything ai strategy draws renewed attention. AIQ has posted double-digi...
The REX AI Equity Premium Income ETF delivers a high headline payout, but its covered-call approach trails the AI ral...
Delta and United just reported, but the big question remains: what's next airline stocks? This guide breaks down the ...
Oracle's shares have fallen steeply as AI hype cooled. This article breaks down whether the stock is a value opportun...
Volatile markets push cautious traders toward targeted bets. This piece highlights three ETFs that blend risk control...
Investing in obesity drugs doesn't have to be a gamble. This guide explains why a proven company with real cash flow ...
As Nvidia prepares to report and guide on May 20, investors weigh the odds of a big move. This article breaks down th...
A recent SEC filing shows Tabor Asset Management increasing its stake in Madison Square Garden Sports, underscoring a...